|
End-of-day quote
Shenzhen S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 6.040 CNY | -0.98% |
|
+2.20% | -18.05% |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 6.21B 920M 795M 747M 679M 1.28B 87.97B 1.3B 8.75B 3.42B 44.05B 3.45B 3.38B 146B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 5.06B 751M 648M 609M 554M 1.04B 71.79B 1.06B 7.14B 2.79B 35.95B 2.82B 2.76B 119B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -0.98% | ||
| 1 week | +2.20% | ||
| Current month | +7.47% | ||
| 1 month | -9.72% | ||
| 3 months | -1.15% | ||
| 6 months | -5.03% | ||
| Current year | -18.05% |
| 1 week | 5.86 |  | 6.24 |
| 1 month | 5.2 | | 6.61 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 2006-04-10 |
Li Ji
DFI | Director of Finance/CFO | 45 | 2023-04-23 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 2006-04-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 2006-04-10 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 2009-04-23 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 2006-04-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/5/25 | Buy | Director | 100 | 0.0000% | ||
| 10/29/25 | Sell | Director | 35,100 | 0.0041% | ||
| 10/28/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | +2.20% | -25.34% | -37.67% | 920M | |
| -2.25% | -0.47% | +68.30% | +115.90% | 1,052B | |
| -0.66% | +0.43% | +47.39% | +50.54% | 627B | |
| -0.54% | +1.39% | +20.69% | +63.99% | 441B | |
| -1.99% | -3.32% | +38.71% | +35.41% | 349B | |
| -1.05% | -2.81% | +23.07% | +35.70% | 287B | |
| -2.12% | -3.67% | -1.14% | +5.37% | 241B | |
| -0.63% | +1.04% | +40.05% | +56.09% | 224B | |
| -1.19% | -3.41% | -9.57% | -52.71% | 202B | |
| +0.16% | +3.87% | +16.89% | +73.73% | 172B | |
| Average | -1.12% | +0.49% | +21.90% | +34.63% | 359.61B | |
| Weighted average by Cap. | -1.36% | +0.32% | +39.07% | +61.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.92M 84.57M 79.47M 72.28M 136M 9.36B 138M 931M 364M 4.69B 368M 360M 15.58B | 624M 92.47M 79.86M 75.05M 68.25M 128M 8.84B 130M 879M 344M 4.43B 347M 340M 14.71B |
| Net income | -74.07M -10.98M -9.48M -8.91M -8.11M -15.24M -1.05B -15.49M -104M -40.83M -526M -41.23M -40.33M -1.75B | -347M -51.48M -44.46M -41.78M -38M -71.44M -4.92B -72.61M -490M -191M -2.46B -193M -189M -8.19B |
| Net Debt | -1.98B -294M -254M -239M -217M -408M -28.1B -415M -2.79B -1.09B -14.07B -1.1B -1.08B -46.77B | -1.14B -169M -146M -137M -125M -235M -16.18B -239M -1.61B -629M -8.1B -635M -622M -26.93B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | CN¥6.040 | -0.98% | 32,968,396 |
| 26-08-13 | CN¥6.100 | +1.33% | 49,967,992 |
| 26-08-12 | CN¥6.020 | +1.01% | 31,341,450 |
| 26-08-11 | CN¥5.960 | -0.33% | 34,345,059 |
| 26-08-10 | CN¥5.980 | +1.18% | 50,019,009 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
